Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance

Phillip A. Schwartz(Pfizer (United States)), Brion W. Murray
Proceedings of the National Academy of Sciences
December 17, 2013
Cited by 277


Related Papers

No related papers found

Powered by citation graph analysis